BRN Discussion Ongoing

[rgupta]

Not sure if everyone has seen this demo from SocioNext on this page. Its clear they are very happy with the sensor fusion and low power solutions of Akida for all their senor inteligence going forward. They are a tier 1 auto supplier using Akida as the SOC solution for the digital car of the future.

They do not have a licence agreement but they have noted that they have partnered with BRN. it still confuses me the different entitlements that a license and a partnership gets a customer but this is clearly a relationship that is close to bringing in ongoing revenues.

Automotive Custom SoC Technologies and Solutions

Socionext’s advanced automotive custom SoC solutions are designed to help OEMs and tier-one automakers achieve differentiating technologies

socionextus.com

I assume as partner they have access to our technology and then those partners provide solutions to their customers. The end customer will pay royalties. Partners can manufacture product with our IP but for demonstration purpose only. If they sell the product then they will pay royalties to brn.
Dyor

 

[jk6199]

Some big hitters in the market today.

Getting in or getting out?

I'm sure a positive outcome from the BRN / ARM talk would be "armless" to the shorts

 

[jtardif999]

The FED last week raised interest rates .25%, but there was some clear language from JP that its very possible that it might be the last.
Tech stocks have been the worst hit in this current enviroment, so should see better than average rebound if no further interest rate rises.
The Nasdaq had a ball tearer on Friday as did many tech stocks on what i believe was the wording from JP.

Its my opinion that BRN was helped by the JP wording , along with the upcoming BRN/ARM Tech Talk (collaboration) and just maybe the shorting activity might be feeling that the s/p is not going much lower. (just a feeling)
Also, we all saw how quickly the BRN s/p retaliated 2 weeks ago after being knocked down into the mid 30s.

ARM COLLABORATION
RENASAS TAPE-OUT

BRN .............................. the most exciting stock on the ASX

AKIDA BALLISTA

Add to this the possibility that the 1500 will tape out soon - perhaps with a Megachips client as the recipient? AIMO.

 

[TopCat]

Add to this the possibility that the 1500 will tape out soon - perhaps with a Megachips client as the recipient? AIMO.

And perhaps Morse Micro IS the client. Have come across this this employee from Morse Micro who has recently published this paper. Sorry about the screen shot quality, not quite sure how to post LinkedIn links.

 

[Vladsblood]

I'm thinking a lot of big fish in Tier1 Worldwide businesses are super interested in the Brainchip/Arm joint conference.
Seriously think our rerating has just started to move now...Just before our AGM too! Nice play Brainchip and Arm teams. Vlad.

 

[MadMayHam | 合氣道]

And perhaps Morse Micro IS the client. Have come across this this employee from Morse Micro who has recently published this paper. Sorry about the screen shot quality, not quite sure how to post LinkedIn links.

View attachment 35925
View attachment 35926 View attachment 35929

Has there been a link established with Morse Micro? From what I understand, they are not currently a partner on Brainchip's website. This paper, from what I understand, is just MM doing software simulations of chip-based SNNs utilising various different models on how the learning happens (no JAST mentioned).

 

[TopCat]

Has there been a link established with Morse Micro? From what I understand, they are not currently a partner on Brainchip's website. This paper, from what I understand, is just MM doing software simulations of chip-based SNNs utilising various different models on how the learning happens (no JAST mentioned).

The only link I know of is that Megachips is an investor in Morse Micro and is helping with the design of their chips.

 

[Bravo]

I think this recent partnership between Teksun (our buddies) and Vivoka might be worth keeping an eye on.

Vivoka & Teksun partner to develop innovative solution – Vivoka

Vivoka and Teksun signed a partnership agreement to collaborate on innovative technology, products, and services.

vivoka.com

 

[Diogenese]

And perhaps Morse Micro IS the client. Have come across this this employee from Morse Micro who has recently published this paper. Sorry about the screen shot quality, not quite sure how to post LinkedIn links.

View attachment 35925
View attachment 35926 View attachment 35929

Thanks TopCat,

This is an analog neuron. The capacitors (Cout, Cahp, Cmem) are a giveaway.

https://www.techrxiv.org/articles/p...ble_Spiking_Frequency_in_22-nm_FDSOI/15042639

It is interesting that they chose 22nm FDSOI technology.

 

[Bravo]

I think this recent partnership between Teksun (our buddies) and Vivoka might be worth keeping an eye on.

View attachment 35945

Vivoka & Teksun partner to develop innovative solution – Vivoka

Vivoka and Teksun signed a partnership agreement to collaborate on innovative technology, products, and services.

vivoka.com

View attachment 35944

I guess it's just purely coincidental that our AKIDA neuromorphic technology is the bees-knees for AI–powered features such as keyword spotting.

 

[rgupta]

The only link I know of is that Megachips is an investor in Morse Micro and is helping with the design of their chips.

Megachips invested $100million last year and may be that makes megachips a major holder in Morse micro. Even megachips is selling MM solutions.

 

[Tothemoon24]

Scientific Validation​

Know Labs is advancing the testing of Bio-RFID, progressing on the path to FDA submission for clearance as a medical-grade device. As we prioritize external validation of our technology and transparency in our progress, we are continuously adding to a growing body of evidence.

Technical Feasibility Clinical Study​

May 5, 2023​

A study titled, “Technical Feasibility of a Novel Sensor for Non-Invasive Blood Glucose Monitoring Compared to Dexcom G6®,” demonstrates that the Bio-RFID sensor can deliver stable, repeatable results in predicting blood glucose concentrations using the Dexcom G6® as a reference device. Results were presented at American Association of Clinical Endocrinology (AACE) 2023 Annual Meeting.
Poster
Abstract

Proof of Principle Study in Collaboration with Mayo Clinic​

April 21, 2023​

A study titled, “Detecting Unique Analyte-Specific Radio Frequency Spectral Responses in Liquid Solutions – Implications for Non-Invasive Physiologic Monitoring,” was conducted in collaboration with Mayo Clinic and demonstrates the accuracy of Know Labs’ non-invasive Bio-RFID technology in quantifying different analytes in vitro. Results were presented at the American Physiological Society 2023 Summit.
Poster
Abstract

Proof of Concept Clinical Study​

February 28, 2023​

This technical report titled, "Non-Invasive Blood Glucose Monitoring: A Validation of a Novel Sensor Compared to a Dexcom G6®," presents proof of concept for a new method to quantify blood glucose levels (BGL) in vivo non-invasively using RF methods by means of training a model to predict readings of the Dexcom G6®, as a proxy for BGL. The method uses a new type of sensing device that rapidly scans a wide band of RF frequencies. The report outlines data science techniques used to train a neural network model to make predictions, and includes metrics of model success and future directions of this work. Results were peer-reviewed by Know Labs Scientific advisory board.

 

[TopCat]

Scientific Validation​

Know Labs is advancing the testing of Bio-RFID, progressing on the path to FDA submission for clearance as a medical-grade device. As we prioritize external validation of our technology and transparency in our progress, we are continuously adding to a growing body of evidence.

Technical Feasibility Clinical Study​

May 5, 2023​

A study titled, “Technical Feasibility of a Novel Sensor for Non-Invasive Blood Glucose Monitoring Compared to Dexcom G6®,” demonstrates that the Bio-RFID sensor can deliver stable, repeatable results in predicting blood glucose concentrations using the Dexcom G6® as a reference device. Results were presented at American Association of Clinical Endocrinology (AACE) 2023 Annual Meeting.
Poster
Abstract

Proof of Principle Study in Collaboration with Mayo Clinic​

April 21, 2023​

A study titled, “Detecting Unique Analyte-Specific Radio Frequency Spectral Responses in Liquid Solutions – Implications for Non-Invasive Physiologic Monitoring,” was conducted in collaboration with Mayo Clinic and demonstrates the accuracy of Know Labs’ non-invasive Bio-RFID technology in quantifying different analytes in vitro. Results were presented at the American Physiological Society 2023 Summit.
Poster
Abstract

Proof of Concept Clinical Study​

February 28, 2023​

This technical report titled, "Non-Invasive Blood Glucose Monitoring: A Validation of a Novel Sensor Compared to a Dexcom G6®," presents proof of concept for a new method to quantify blood glucose levels (BGL) in vivo non-invasively using RF methods by means of training a model to predict readings of the Dexcom G6®, as a proxy for BGL. The method uses a new type of sensing device that rapidly scans a wide band of RF frequencies. The report outlines data science techniques used to train a neural network model to make predictions, and includes metrics of model success and future directions of this work. Results were peer-reviewed by Know Labs Scientific advisory board.

Edge Impulse, the industry-leading development toolkit for machine learning, is collaborating with Know Labs to accelerate Bio-RFID’s algorithm refinement, an essential step for interpreting its existing robust data set and ultimately supporting large-scale clinical trials. Edge Impulse has partnered with companies in similar stages of development across a variety of fields in health, health wearable technology, agriculture and infrastructure. “We’ve spent the last six months working alongside Know Labs’ software team to accelerate algorithm development for their non-invasive glucose monitor and are reminded each day how incredible it is to demonstrate algorithm performance in such novel data,” said Zach Shelby, co-founder and CEO of Edge Impulse.

World’s first non-invasive blood glucose monitor on the cards as Know Labs engages new partners for FDA clearance acceleration

Know Labs, the company behind the development of Bio-RFID technology, has revealed its numerous strong partnerships as it targets FDA approval for its non-invasive glucose monitoring devices, the KnowU and UBand. The firm has acquired assistance in vital areas such as machine learning, product...

www.notebookcheck.net

 

[Deleted member 118]

The jobs AI won’t take yet

Amid the talk of artificial intelligence replacing workers, experts say there are some jobs computers aren’t taking – at least for a while.

www.bbc.com

 

[Stable Genius]

https://www.linkedin.com/posts/must...0-3CjH?utm_source=share&utm_medium=member_ios


Deloittes expectations for the semi-conductor market in India by 2026 looks pretty good.

I’m looking to invest but I just need to find a semi-conductor company with links to major companies in the Indian Market, maybe TATA, Moschips or VVDN and with some luck already has a SOC with RENESAS in the pipeline.

Looking for a company with potential, maybe having a revolutionary AI commercially available chip or IP and presence in India would be nice.

I’d be very surprised if I can find one ticking those boxes for less than $1.

A company that could achieve even 1% of the US $56B would be quite profitable, let alone global results!

Edit; After re-reading the MOSCHIPS post this may be jobs/skills cost to industry, maybe not market size. Either way I’m still looking for a company with growth potential!

 

[Tothemoon24]

Stumbled across this pic ; perhaps one of our residents Brain techs may be able to shed some light if any relevance
If Health Preventive monitoring stops one from perving I have no intentions of owning a merc

 

[Sirod69]

Top 4 Machine Learning Use Cases for AI-Savvy Hardware Companies​

Adam Benzion​

Senior Vice President at Edge Impulse
8. Mai 2023

As hardware companies face increased competition, shorter product cycles, and growing demand for more intelligent devices, machine learning is becoming essential for achieving fast, efficient, and measurable results. Without mastering this field, everyone who's working on hardware from medical devices, to agriculture machines, factory equipment and fitness wearables will fall behind and fast. Leading embedded ML platforms from Edge Impulse, to #Microsoft Azure Machine Learning, #Google TensorFlow and #AWS SageMaker offer powerful embedded tools that help hardware companies build AI-savvy products that are years ahead of the competition, critically efficient, and differentiated.

Explore the top 5 machine learning use cases for hardware companies seeking modern #AI capabilities and what to look for when choosing an ML platform:

https://www.linkedin.com/pulse/top-5-machine-learning-use-cases-ai-savvy-hardware-adam-benzion%3FtrackingId=JcCEnoY3JogXvczYTEW51g%253D%253D/?trackingId=JcCEnoY3JogXvczYTEW51g%3D%3D

 

[IloveLamp]

Coach for Efficient Driving: Tech Views in the VISION EQXX

Coach for Efficient Driving: Tech Views in the VISION EQXX

The VISION EQXX is the most efficient Mercedes-Benz ever built. It proved this last year with not one but two road trips, from our Sindelfingen and Untertürkheim to Cassis in the South of France and the legendary Silverstone racetrack in the UK.

www.linkedin.com

 

[Dallas]

ANT61 on LinkedIn: Satellite docking robot

🚀🤖 Meet Mr Fix-it at Space Forum 15 2023! 🤖🚀 Heads up, space fans! We're excited to showcase our "out-of-this-world" satellite-repairing robots at Space…

www.linkedin.com